Vilin Bio Med Limited — Important, 18-06-2026: Updates

Vilin Bio Med's board approved strong financial results for the year ended March 31, 2026. Revenue from operations surged to Rs 42.26 Cr (vs Rs 14.81 Cr YoY), with profit at Rs 1.93 Cr (vs Rs 0.22 Cr YoY). The company confirmed no deviation in using Rs 3.38 Cr raised via preferential issue. Cash and cash equivalents also saw significant growth.